当其他一切都失败了,试试这个:HeartMate III左心室辅助设备
1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Cardiovascular Center, 1500 East Medical Center Drive SPC 5853, Ann Arbor, MI 48109, USA.
Heart failure clinics
|August 31, 2024
概括
心力衰竭 (HF) 是一种影响许多人的渐进性疾病. 连续流动左心室辅助器件 (LVADs) 为晚期心脏病患者提供了一种拯救生命的选择,当心脏移植无法实现时.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭管理的管理
背景情况:
- 心力衰竭 (HF) 是一种渐进的疾病,有相当多的患者群体经历了先进的阶段.
- 超过25万名患者患有晚期心力衰竭,减少排气分数 (HFrEF),对医疗治疗没有反应.
- 移植供体心脏的稀缺性需要替代的先进疗法.
研究的目的:
- 为提供对晚期心力衰竭的左心室辅助器件 (LVAD) 治疗进行最新的审查.
- 详细说明LVAD植入的当前指示和禁忌.
- 为了总结与LVAD相关的不良事件和结果,支持.
主要方法:
- 这项研究是对当前文献和临床数据的综述.
- 它综合了关于LVADs作为高级HFrEF治疗的信息.
- 专注于患者选择,并发症和生存数据.
主要成果:
- 左心室辅助装置 (LVAD) 是符合条件的高级心力衰竭患者的关键干预措施.
- 该审查概述了患者选择的具体标准,并确定了潜在的风险.
- 目前的结果数据表明LVADs在改善生存率和生活质量的有效性.
结论:
- 连续流动LVAD代表了高级HFrEF和有限的移植可用性患者的重要治疗选择.
- 了解指示,禁忌和不良事件对于成功实施LVAD至关重要.
- LVAD疗法提供了一种拯救生命的解决方案,改善了具有挑战性的患者队列的结果.
相关概念视频
01:23Mechanical Ventilation III: Noninvasive Ventilation
87
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
87
01:26Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545